Does familial hypertriglyceridemia predispose to NIDDM?

Diabetes Care. 1993 Nov;16(11):1494-501. doi: 10.2337/diacare.16.11.1494.

Abstract

Objective: To determine the 10-yr incidence of impaired glucose tolerance and NIDDM in families with a clustering of endogenous hypertriglyceridemia.

Research design and methods: The prospective population study, where the oral glucose tolerance test and the measurement of serum lipids and lipoproteins were performed at the baseline examination and after the 10-yr follow-up, was conducted on 56 subjects (17-60 yr of age at the baseline). The subjects were from six pedigrees with a clustering of endogenous hypertriglyceridemia, and 47 of these subjects attended the follow-up 10 yr later.

Results: In the study families, the prevalence of glucose intolerance and NIDDM increased from 15 to 49% (P < 0.001) and from 2 to 21% (P < 0.001), respectively, over the 10-yr period. When grouped according to the baseline serum triglyceride tertiles, 76% (P < 0.01) of the family members with highest serum triglycerides were glucose intolerant (29% impaired glucose tolerance, 47% NIDDM) at follow-up compared with 20% of those with lowest serum triglycerides. In discriminant analysis, including age, body mass index, treatment with thiazides and beta-blocking agents, and 2-h serum insulin concentration, the baseline serum triglycerides still remained as an independent predictor of development of impaired glucose tolerance and NIDDM.

Conclusions: Families with a clustering of hypertriglyceridemia are at increased risk of NIDDM, and in these families elevation of serum triglycerides serves as a risk marker of glucose intolerance and NIDDM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • Body Mass Index
  • Causality
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Female
  • Follow-Up Studies
  • Glucose Intolerance
  • Glucose Tolerance Test
  • Humans
  • Hyperlipoproteinemia Type IV / blood
  • Hyperlipoproteinemia Type IV / complications*
  • Incidence
  • Insulin / blood
  • Lipids / blood
  • Lipoproteins / blood
  • Male
  • Middle Aged
  • Pedigree
  • Prospective Studies
  • Risk Factors
  • Triglycerides / blood

Substances

  • Biomarkers
  • Insulin
  • Lipids
  • Lipoproteins
  • Triglycerides